APA (7th ed.) Citation

Škorić, B., Jovanović, M., Kuzmanović, M., Miljković, B., & Vučićević, K. (2024). Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies. European journal of clinical pharmacology, 80(5), 697-705. https://doi.org/10.1007/s00228-024-03642-4

Chicago Style (17th ed.) Citation

Škorić, Biljana, Marija Jovanović, Miloš Kuzmanović, Branislava Miljković, and Katarina Vučićević. "Understanding Hemoglobin Contribution to High-dose Methotrexate Disposition—population Pharmacokinetics in Pediatric Patients with Hematological Malignancies." European Journal of Clinical Pharmacology 80, no. 5 (2024): 697-705. https://doi.org/10.1007/s00228-024-03642-4.

MLA (9th ed.) Citation

Škorić, Biljana, et al. "Understanding Hemoglobin Contribution to High-dose Methotrexate Disposition—population Pharmacokinetics in Pediatric Patients with Hematological Malignancies." European Journal of Clinical Pharmacology, vol. 80, no. 5, 2024, pp. 697-705, https://doi.org/10.1007/s00228-024-03642-4.